AIXN · As filed with the SEC

AiXin Life International income statement, by fiscal year

The statement as AiXin Life International presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Statements of Operations and Comprehensive Loss · USD, except per-share amounts

USD, except per-share amountsFY2025
Year ended Dec 31, 2025
FY2024
Year ended Dec 31, 2024
FY2023
Year ended Dec 31, 2023
Sales revenue
Total revenues, net1,489,4273,824,3014,089,799
Direct Sales171,949504,0971,159,134
Pharmacy107,198822,958937,655
Hotel408,581585,6341,194,829
Manufacture and Sale801,6991,911,612798,181
Operating costs and expenses
Cost of Revenue867,8211,767,3641,613,950
Hotel operating costs1,082,5381,447,5991,811,065
Selling, General and Administrative Expense507,743791,104888,745
Selling, General and Administrative Expense1,551,8752,105,2981,903,306
Stock-Based Compensation Expense—301,127371,540
Total operating costs and expenses4,009,9776,412,4926,588,606
Loss from operations(2,520,550)(2,588,191)(2,498,807)
Non-operating income (expenses)
Net Interest Income(18,589)(76,613)838
Interest Expense467,695——
Non-Operating Income (Expense)29,372(103,009)426,794
Total non-operating income (expenses), net478,478(179,622)427,632
Loss before income tax(2,042,072)(2,767,813)(2,071,175)
Income Tax Expense39152819,519
Net loss(2,042,463)(2,768,341)(2,090,694)
Other comprehensive items
Foreign currency translation gain (loss)(243,885)96,3928,301
Comprehensive loss(2,286,348)(2,671,949)(2,082,393)
Earnings Per Share (Basic)(0.08)(0.11)(0.08)
Earnings Per Share (Diluted)(0.08)(0.11)(0.08)
Weighted Average Shares Outstanding24,999,83424,999,83424,999,834
Weighted Average Shares Outstanding, Diluted24,999,83424,999,83424,999,834

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.